The Centers for Medicare & Medicaid Services just announced 15 new drugs it wants to lower the cost for including popular, ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Up to 3.4 million eligible patients could benefit from the medication that treats type 2 diabetes and aids weight loss ...

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections - As drugs emerge as vital to the Government’s ...

Half of UK adults say they’ve put off even trying to lose weight, with Gen Z most likely to delay  More than one in five UK adults (22%) have delayed losing weight for three years or more  Four in ...